Garrison Bradford & Associates Inc Volitionrx LTD Transaction History

Garrison Bradford & Associates Inc

  • $100 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 23, 2022
SELL
$1.96 - $3.05 $30,380 - $47,275
-15,500 Closed
0 $0
Q3 2017

Nov 09, 2017
BUY
$2.45 - $2.98 $37,975 - $46,190
15,500
15,500 $41,000

Others Institutions Holding VNRX

# of Institutions
31
Shares Held
8.19M
Call Options Held
53.6K
Put Options Held
300
View Full List

About VOLITIONRX LTD

VNRX Quotes by TradingView
  • Ticker VNRX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 57,297,000
  • Market Cap $37.2M
  • Description
  • VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating sampl...
More about VNRX
Track This Portfolio

Track Garrison Bradford & Associates Inc Portfolio

Follow Garrison Bradford & Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Garrison Bradford & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Garrison Bradford & Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email